TGFB1 and pulmonary fibrosis: In conclusion, our in vitro study using IPF lung fibroblasts and the in vivo study in a mouse model of TGFβ-induced lung fibrosis demonstrate that combining esomeprazole with pirfenidone improves antifibrotic efficacy of the now standard of care antifibrotic drug pirfenidone.